CLNN
Clene Inc

3,098
Loading...
Loading...
News
all
press releases
Clene Inc. (CLNN) Reports Q2 Loss, Misses Revenue Estimates
Clene (CLNN) delivered earnings and revenue surprises of -59.18% and -73.00%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·28d ago
News Placeholder
More News
News Placeholder
MeiraGTx Holdings PLC (MGTX) Reports Q2 Loss, Beats Revenue Estimates
MeiraGTx (MGTX) delivered earnings and revenue surprises of +7.69% and +59.78%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·28d ago
News Placeholder
Absci Corporation (ABSI) Reports Q2 Loss, Misses Revenue Estimates
ABSCI CORP (ABSI) delivered earnings and revenue surprises of -26.32% and -74.44%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
Castle Biosciences, Inc. (CSTL) Q2 Earnings and Revenues Surpass Estimates
Castle Biosciences (CSTL) delivered earnings and revenue surprises of +129.41% and +16.64%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
Clene Announces Reverse Stock Split and Share Structure Changes
Clene (CLNN) has issued an announcement. On July 8, 2024, Clene Inc. announced a 1-for-20 reverse stock split, effective July 11, 2024, after filin...
TipRanks Financial Blog·1y ago
News Placeholder
Analyst Scoreboard: 5 Ratings For Clene
Latest Ratings for CLNN DateFirmActionFromTo May 2021Maxim GroupInitiates Coverage OnBuy May 2021Cantor FitzgeraldInitiates Coverage OnOverweight Mar 2021BenchmarkInitiates Coverage OnBuy View...
Benzinga·1y ago
News Placeholder
Roth Capital Equities Analysts Cut Earnings Estimates for Clene Inc. (NASDAQ:CLNN)
Clene Inc. (NASDAQ:CLNN Free Report) Investment analysts at Roth Capital decreased their Q1 2024 earnings per share (EPS) estimates for Clene in a report issued on Wednesday, March...
Zolmax·1y ago
News Placeholder
IBN Announces First in Human Podcast Featuring Clene Inc. CEO Rob Etherington
LOS ANGELES, March 19, 2024 (GLOBE NEWSWIRE) -- via IBN IBN, a multifaceted communications organization engaged in connecting public companies with the investment community, today announces that...
Globe Newswire·1y ago
News Placeholder
Clene announces peer-reviewed publication on CNM-Au8
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
The Fly·1y ago
News Placeholder
Clene Announces Peer-Reviewed Publication Characterizing the Protein Corona of the Investigational Neurodegenerative Disease Drug, CNM-Au8
Proprietary catalytic gold nanocrystals comprising Clene's investigational drug CNM-Au8 develop a protein corona upon exposure to human blood plasma comprised of proteins that promote blood-brain...
Globe Newswire·1y ago

Latest CLNN News

View

Advertisement. Remove ads.

Advertisement. Remove ads.